폐활량계 시장 : 시장 규모 및 점유율 산업 분석(유형별, 제품 유형별, 용도별, 최종사용자별, 지역별), 전망 및 예측(2026-2033년)

The Global Spirometer Market is expected to reach USD 1511.6 million by 2033, growing at a CAGR of 7.9% during (2026 - 2033).

Increasing demand for respiratory disease diagnosis, pulmonary function assessment, continuous lung health monitoring, and routine pulmonary care is driving the Spirometer Market across hospitals, clinics, diagnostic centers, and homecare settings. Growing awareness of respiratory health, preventive screening programs, portable devices, handheld spirometers, wireless connectivity, cloud-based data management, and remote monitoring capabilities is further strengthening market adoption. The market originated from the early need to quantitatively assess pulmonary function through devices designed to measure lung volumes. Initially, spirometers were mechanical and mainly used in clinical environments for diagnosing respiratory conditions such as tuberculosis and asthma.

Key Market Trends & Insights

• By type, Volume Measurement dominated the market in 2025 with USD 595.7 million and is projected to reach USD 1,058.0 million by 2033, growing at a CAGR of 7.6% during (2026 - 2033).
• Peak Flow Meters is expected to grow faster by type, registering a CAGR of 8.5% during (2026 - 2033), supported by portable, affordable, and convenient respiratory monitoring demand.
• By product type, Devices dominated the market in 2025 with USD 474.8 million and is projected to reach USD 838.8 million by 2033, growing at a CAGR of 7.5% during (2026 - 2033).
• Software is expected to grow fastest by product type, registering a CAGR of 8.7% during (2026 - 2033), driven by EHR integration, cloud-based data management, automated interpretation, and remote monitoring platforms.
• By application, Chronic Obstructive Pulmonary Disorder (COPD) dominated the market in 2025 with USD 417.2 million and is projected to reach USD 726.9 million by 2033, growing at a CAGR of 7.3% during (2026 - 2033).
• Other Application is expected to grow fastest by application, registering a CAGR of 8.5% during (2026 - 2033), supported by occupational health assessments, preoperative evaluation, respiratory screening, and broader pulmonary monitoring use cases.
• By end user, Hospitals dominated the market in 2025 with USD 272.9 million and is projected to reach USD 465.3 million by 2033, while Homecare Settings is expected to grow faster with a CAGR of 9.0% during (2026 - 2033).
• Regionally, North America dominated the market in 2025 with USD 318.3 million and is projected to reach USD 565.1 million by 2033, while LAMEA is expected to grow fastest with a CAGR of 10.0% during (2026 - 2033).

This market is witnessing growth as chronic respiratory disease management, asthma control, COPD diagnosis, preventive screening, and pulmonary function assessment become more important across healthcare systems. Digital spirometers are increasingly being integrated with mobile applications, electronic health records, telemedicine platforms, cloud storage, and automated reporting systems. Portable and connected devices are expanding the use of spirometry beyond hospitals into outpatient clinics, diagnostic centers, homecare, occupational health, and remote patient monitoring programs.

This market is moderately fragmented and technology-driven, with competition led by respiratory diagnostics specialists, pulmonary function testing companies, and diversified medical device firms. Companies compete through device accuracy, portability, software integration, cloud connectivity, automated quality control, ease of use, and interoperability with digital health platforms. Future competition will depend on AI-assisted interpretation, remote monitoring, home-use devices, software-enabled workflow integration, regulatory compliance, and broader adoption across primary care and decentralized healthcare settings.

Drivers

• Increasing Prevalence of Respiratory and Chronic Diseases Driving Spirometer Demand
• Integration of Digital Health Technologies Enhancing Spirometer Capabilities
• Rising Focus on Evidence-Based Healthcare and Data-Driven Clinical Decision Making
• Expanding Applications in Emerging Healthcare Markets and Growing Telemedicine Programs

Restraints

• Regulatory Challenges and Compliance Burden
• High Cost and Reimbursement Limitations
• Technical and Operational Limitations in Integration and Data Interoperability

Opportunities

• Integration of Digital Health Technologies to Enhance Spirometer Utility and Patient Engagement
• Expansion into Emerging Markets through Affordable and Portable Spirometry Solutions
• Advancement of Artificial Intelligence-Driven Spirometry for Enhanced Diagnostic Precision and Personalized Respiratory Care

Challenges

• Technical Limitations in Spirometer Devices and Data Integration
• Regulatory and Compliance Barriers Impacting Market Penetration
• High Costs and Economic Barriers Limiting Accessibility and Adoption

Market Share Analysis

The global Spirometer Market is moderately fragmented, with Vyaire Medical, NDD Medical Technologies, and Medical International Research forming the leading competitive tier across hospital pulmonary laboratories, primary care, clinical research, and portable spirometry applications. Vitalograph, SCHILLER, and MGC Diagnostics strengthen the second tier through advanced PFT systems, clinical trial spirometry, and integrated cardiopulmonary diagnostic platforms. COSMED, Geratherm Respiratory, Ganshorn Medizin Electronic, and Fukuda Sangyo support competition across specialized pulmonary diagnostics, research, and regional healthcare markets. Future competition will be shaped by connected spirometry, AI-assisted interpretation, cloud-enabled pulmonary data management, remote monitoring, and home-based respiratory assessment.

Type Outlook

Based on Type, the market is segmented into Volume Measurement and Peak Flow Meters. The Volume Measurement market dominated the Global Spirometer Market by Type in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 1057.9 million by 2033, growing at a CAGR of 7.6 % during the forecast period. The Peak Flow Meters market is expected to witness a CAGR of 8.5% during (2026 - 2033).

Volume Measurement leads the market due to its extensive use in comprehensive pulmonary function testing across hospitals, pulmonary laboratories, specialty clinics, and diagnostic centers. These systems support detailed assessment of lung volumes, airflow, and respiratory performance, making them important for COPD, asthma, restrictive lung disorders, and other pulmonary conditions. Peak Flow Meters remain important for affordable and convenient respiratory monitoring, particularly in asthma management, outpatient care, home-based tracking, and routine airflow limitation assessment.

Product Type Outlook

Based on Product Type, the market is segmented into Devices, Accessories & Consumables, and Software. The Devices market dominated the Global Spirometer Market by Product Type in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 838.8 million by 2033, growing at a CAGR of 7.5 % during the forecast period. The Accessories & Consumables market is expected to witness a CAGR of 8.1% during (2026 - 2033). The Software market is expected to witness a CAGR of 8.7% during (2026 - 2033).

Devices represent the leading product category, supported by continued adoption of portable, handheld, and desktop spirometry systems for clinical and remote respiratory assessment. Accessories & Consumables are supported by recurring demand for mouthpieces, bacterial and viral filters, tubing, sensors, calibration tools, and other components required for hygiene and reliable testing. Software is gaining importance as spirometry becomes increasingly connected to electronic health records, automated interpretation tools, cloud-based data management, reporting platforms, and remote patient-monitoring systems.

Application Outlook

Based on Application, the market is segmented into Chronic Obstructive Pulmonary Disorder (COPD), Asthma, and Other Application. The Chronic Obstructive Pulmonary Disorder (COPD) market dominated the Global Spirometer Market by Application in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 726.8 million by 2033, growing at a CAGR of 7.3 % during the forecast period. The Asthma market is expected to witness a CAGR of 8.3% during (2026 - 2033). Additionally, The Other Application market is expected to witness highest CAGR of 8.5% during (2026 - 2033).

COPD represents the leading application area as spirometry is essential for detecting persistent airflow limitation, assessing disease severity, monitoring progression, and evaluating treatment outcomes. Asthma remains a major application as pulmonary function testing helps clinicians evaluate variable airflow obstruction, monitor respiratory performance, and support long-term disease control. Other Application includes occupational health assessments, preoperative evaluation, respiratory screening, clinical research, and monitoring of other pulmonary conditions.

End User Outlook

Based on End User, the market is segmented into Hospitals, Physician & Clinics, Diagnostic Centers, Homecare Settings, and Other Facilities. The Hospitals market dominated the Global Spirometer Market by End User in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 465.3 million by 2033, growing at a CAGR of 7 % during the forecast period. The Physician & Clinics market is expected to witness a CAGR of 7.6% during (2026 - 2033). Additionally, The Diagnostic Centers market is expected to witness highest CAGR of 8.2% during (2026 - 2033).

Hospitals lead the market due to substantial patient volumes, established pulmonary departments, comprehensive diagnostic infrastructure, and routine respiratory function testing. Physician & Clinics are gaining demand as compact and portable spirometers support outpatient pulmonary assessment and primary care screening. Diagnostic Centers remain important due to specialized respiratory testing services, while Homecare Settings are expanding through connected and portable devices that support remote monitoring and long-term chronic disease management. Other Facilities include rehabilitation centers, occupational health facilities, research institutions, and specialized care environments.

Regional Outlook

Region-wise, the Spirometer Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America market dominated the Global Spirometer Market by Region in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 565.1 million by 2033, growing at a CAGR of 7.6 % during the forecast period. The Europe market is expected to witness a CAGR of 7.2% during (2026 - 2033). Additionally, The Asia Pacific market is expected to witness a CAGR of 7.6% during (2026 - 2033).

North America leads the market due to established respiratory care infrastructure, high pulmonary function testing volumes, strong adoption of advanced diagnostic systems, and favorable access to specialized healthcare services. Europe is supported by respiratory disease management programs, standardized pulmonary function testing, and strong clinical infrastructure. Asia Pacific is expanding due to improving healthcare expenditure, growing respiratory disease awareness, diagnostic infrastructure development, and increasing access to pulmonary testing technologies. LAMEA is gradually growing through healthcare infrastructure development and adoption of portable and digital spirometry systems.

Recent Strategies Deployed in the Market

• 2024-September: Vitalograph acquired Morgan Scientific to strengthen its U.S. respiratory diagnostics presence, advanced pulmonary function testing capabilities, and software-supported spirometry platform.
• 2024-August: Trudell Medical agreed to acquire Vyaire Medical's Respiratory Diagnostics business, expanding its position from respiratory care devices into pulmonary function assessment.
• 2024-April: Clario acquired ArtiQ to integrate artificial intelligence with spirometry and respiratory testing, supporting automated test quality feedback and digital respiratory analytics.
• 2024-November: ndd Medical Technologies launched EasyOne Sky, a connected spirometry platform with built-in coaching, cloud integration, automated quality grading, and ultrasonic measurement technology.
• Vitalograph launched the VitaloPFT Series, expanding from conventional spirometry into comprehensive pulmonary function diagnostics for hospitals and secondary-care facilities.
• 2024-May: Morgan Scientific partnered with ZEPHYRx to integrate remote spirometry with ComPAS2 software, supporting connected pulmonary function workflows and remote lung-function monitoring.

List of Key Companies Profiled

• Vyaire Medical, Inc.
• NDD Medical Technologies
• Medical International Research S.p.A.
• Vitalograph Ltd.
• SCHILLER AG
• MGC Diagnostics Corporation
• COSMED S.r.l.
• Geratherm Respiratory GmbH
• Ganshorn Medizin Electronic GmbH
• Fukuda Sangyo Co., Ltd.

Global Spirometer Market Report Segmentation

By Type

• Volume Measurement
• Peak Flow Meters

By Product Type

• Devices
• Accessories & Consumables
• Software

By Application

• Chronic Obstructive Pulmonary Disorder (COPD)
• Asthma
• Other Application

By End User

• Hospitals
• Physician & Clinics
• Diagnostic Centers
• Homecare Settings
• Other Facilities

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Research Scope & Methodology

• 1.1 Market Definition
• 1.2 Analysis Period & Currency
• 1.3 Segmentation
• 1.4 Spirometer Market, by Geography
• 1.5 Research Methodology

Chapter 2. Market Overview

• 2.1 COVID-19 Impact
• 2.2 Market Composition and Scenario

Chapter 3. Key Factors Impacting Market

• 3.1 Market Drivers
• 3.2 Market Restraints
• 3.3 Market Opportunities
• 3.4 Market Challenges
• 3.5 Market Trends
• 3.6 State of Competition
• 3.7 Market Consolidation
• 3.8 Key Customer Criteria

Chapter 4. Product Life Cycle

Chapter 5. Value Chain Analysis of Spirometer Market

Chapter 6. Competition Analysis - Global

• 6.1 Market Share Analysis
• 6.2 Recent Developments
  • 6.2.1 Mergers & Acquisitions
  • 6.2.2 Product Launch & Product Expansion
  • 6.2.3 Partnership, Collaboration & Agreements
  • 6.2.4 Geographical Expansion

Chapter 7. Segmentation By Type

• 7.1 Volume Measurement
• 7.2 Peak Flow Meters

Chapter 8. Segmentation By Product Type

• 8.1 Devices
• 8.2 Accessories & Consumables
• 8.3 Software

Chapter 9. Segmentation By Application

• 9.1 Chronic Obstructive Pulmonary Disorder (COPD)
• 9.2 Asthma
• 9.3 Other Application

Chapter 10. Segmentation By End User

• 10.1 Hospitals
• 10.2 Physician & Clinics
• 10.3 Diagnostic Centers
• 10.4 Homecare Settings
• 10.5 Other Facilities

Chapter 11. North America Market

• 11.1 Market Overview
• 11.2 Key Factors Impacting Market
  • 11.2.1 Market Drivers
  • 11.2.2 Market Restraints
  • 11.2.3 Market Opportunities
  • 11.2.4 Market Challenges
  • 11.2.5 Market Trends
  • 11.2.6 State of Competition
  • 11.2.7 Market Consolidation
  • 11.2.8 Key Customer Criteria
• 11.3 Product Life Cycle
• 11.4 Segmentation By Type
  • 11.4.1 Volume Measurement
  • 11.4.2 Peak Flow
• 11.5 Segmentation By Product Type
  • 11.5.1 Devices
  • 11.5.2 Accessories & Consumables
  • 11.5.3 Software
• 11.6 Segmentation By Application
  • 11.6.1 Chronic Obstructive Pulmonary Disorder (COPD)
  • 11.6.2 Asthma
  • 11.6.3 Other Applications
• 11.7 Segmentation By End User
  • 11.7.1 Hospitals
  • 11.7.2 Physician & Clinics
  • 11.7.3 Diagnostic Centers
  • 11.7.4 Homecare Settings
  • 11.7.5 Other Facilities
• 11.8 Segmentation By Country
  • 11.8.1 US
    • 11.8.1.1 Segmentation By Type
      • 11.8.1.1.1 Volume Measurement
      • 11.8.1.1.2 Peak Flow
    • 11.8.1.2 Segmentation By Product Type
      • 11.8.1.2.1 Devices
      • 11.8.1.2.2 Accessories & Consumables
      • 11.8.1.2.3 Software
    • 11.8.1.3 Segmentation By Application
      • 11.8.1.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 11.8.1.3.2 Asthma
      • 11.8.1.3.3 Other Applications
    • 11.8.1.4 Segmentation By End User
      • 11.8.1.4.1 Hospitals
      • 11.8.1.4.2 Physician & Clinics
      • 11.8.1.4.3 Diagnostic Centers
      • 11.8.1.4.4 Homecare Settings
      • 11.8.1.4.5 Other Facilities
  • 11.8.2 Canada
    • 11.8.2.1 Segmentation By Type
      • 11.8.2.1.1 Volume Measurement
      • 11.8.2.1.2 Peak Flow
    • 11.8.2.2 Segmentation By Product Type
      • 11.8.2.2.1 Devices
      • 11.8.2.2.2 Accessories & Consumables
      • 11.8.2.2.3 Software
    • 11.8.2.3 Segmentation By Application
      • 11.8.2.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 11.8.2.3.2 Asthma
      • 11.8.2.3.3 Other Applications
    • 11.8.2.4 Segmentation By End User
      • 11.8.2.4.1 Hospitals
      • 11.8.2.4.2 Physician & Clinics
      • 11.8.2.4.3 Diagnostic Centers
      • 11.8.2.4.4 Homecare Settings
      • 11.8.2.4.5 Other Facilities
  • 11.8.3 Mexico
    • 11.8.3.1 Segmentation By Type
      • 11.8.3.1.1 Volume Measurement
      • 11.8.3.1.2 Peak Flow
    • 11.8.3.2 Segmentation By Product Type
      • 11.8.3.2.1 Devices
      • 11.8.3.2.2 Accessories & Consumables
      • 11.8.3.2.3 Software
    • 11.8.3.3 Segmentation By Application
      • 11.8.3.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 11.8.3.3.2 Asthma
      • 11.8.3.3.3 Other Applications
    • 11.8.3.4 Segmentation By End User
      • 11.8.3.4.1 Hospitals
      • 11.8.3.4.2 Physician & Clinics
      • 11.8.3.4.3 Diagnostic Centers
      • 11.8.3.4.4 Homecare Settings
      • 11.8.3.4.5 Other Facilities
  • 11.8.4 Rest of North America
    • 11.8.4.1 Segmentation By Type
      • 11.8.4.1.1 Volume Measurement
      • 11.8.4.1.2 Peak Flow
    • 11.8.4.2 Segmentation By Product Type
      • 11.8.4.2.1 Devices
      • 11.8.4.2.2 Accessories & Consumables
      • 11.8.4.2.3 Software
    • 11.8.4.3 Segmentation By Application
      • 11.8.4.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 11.8.4.3.2 Asthma
      • 11.8.4.3.3 Other Applications
    • 11.8.4.4 Segmentation By End User
      • 11.8.4.4.1 Hospitals
      • 11.8.4.4.2 Physician & Clinics
      • 11.8.4.4.3 Diagnostic Centers
      • 11.8.4.4.4 Homecare Settings
      • 11.8.4.4.5 Other Facilities

Chapter 12. Europe Market

• 12.1 Market Overview
• 12.2 Key Factors Impacting Market
  • 12.2.1 Market Drivers
  • 12.2.2 Market Restraints
  • 12.2.3 Market Opportunities
  • 12.2.4 Market Challenges
  • 12.2.5 Market Trends
  • 12.2.6 State of Competition
  • 12.2.7 Market Consolidation
  • 12.2.8 Key Customer Criteria
• 12.3 Product Life Cycle
• 12.4 Segmentation By Type
  • 12.4.1 Volume Measurement
  • 12.4.2 Peak Flow Meters
• 12.5 Segmentation By Product Type
  • 12.5.1 Devices
  • 12.5.2 Accessories & Consumables
  • 12.5.3 Software
• 12.6 Segmentation By Application
  • 12.6.1 Chronic Obstructive Pulmonary Disorder (COPD)
  • 12.6.2 Asthma
  • 12.6.3 Other Application
• 12.7 Segmentation By End User
  • 12.7.1 Hospitals
  • 12.7.2 Physician & Clinics
  • 12.7.3 Diagnostic Centers
  • 12.7.4 Homecare Settings
  • 12.7.5 Other Facilities
• 12.8 Segmentation By Country
  • 12.8.1 Germany
    • 12.8.1.1 Segmentation By Type
      • 12.8.1.1.1 Volume Measurement
      • 12.8.1.1.2 Peak Flow
    • 12.8.1.2 Segmentation By Product Type
      • 12.8.1.2.1 Devices
      • 12.8.1.2.2 Accessories & Consumables
      • 12.8.1.2.3 Software
    • 12.8.1.3 Segmentation By Application
      • 12.8.1.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 12.8.1.3.2 Asthma
      • 12.8.1.3.3 Other Applications
    • 12.8.1.4 Segmentation By End User
      • 12.8.1.4.1 Hospitals
      • 12.8.1.4.2 Physician & Clinics
      • 12.8.1.4.3 Diagnostic Centers
      • 12.8.1.4.4 Homecare Settings
      • 12.8.1.4.5 Other Facilities
  • 12.8.2 UK
    • 12.8.2.1 Segmentation By Type
      • 12.8.2.1.1 Volume Measurement
      • 12.8.2.1.2 Peak Flow
    • 12.8.2.2 Segmentation By Product Type
      • 12.8.2.2.1 Devices
      • 12.8.2.2.2 Accessories & Consumables
      • 12.8.2.2.3 Software
    • 12.8.2.3 Segmentation By Application
      • 12.8.2.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 12.8.2.3.2 Asthma
      • 12.8.2.3.3 Other Applications
    • 12.8.2.4 Segmentation By End User
      • 12.8.2.4.1 Hospitals
      • 12.8.2.4.2 Physician & Clinics
      • 12.8.2.4.3 Diagnostic Centers
      • 12.8.2.4.4 Homecare Settings
      • 12.8.2.4.5 Other Facilities
  • 12.8.3 France
    • 12.8.3.1 Segmentation By Type
      • 12.8.3.1.1 Volume Measurement
      • 12.8.3.1.2 Peak Flow
    • 12.8.3.2 Segmentation By Product Type
      • 12.8.3.2.1 Devices
      • 12.8.3.2.2 Accessories & Consumables
      • 12.8.3.2.3 Software
    • 12.8.3.3 Segmentation By Application
      • 12.8.3.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 12.8.3.3.2 Asthma
      • 12.8.3.3.3 Other Applications
    • 12.8.3.4 Segmentation By End User
      • 12.8.3.4.1 Hospitals
      • 12.8.3.4.2 Physician & Clinics
      • 12.8.3.4.3 Diagnostic Centers
      • 12.8.3.4.4 Homecare Settings
      • 12.8.3.4.5 Other Facilities
  • 12.8.4 Russia
    • 12.8.4.1 Segmentation By Type
      • 12.8.4.1.1 Volume Measurement
      • 12.8.4.1.2 Peak Flow
    • 12.8.4.2 Segmentation By Product Type
      • 12.8.4.2.1 Devices
      • 12.8.4.2.2 Accessories & Consumables
      • 12.8.4.2.3 Software
    • 12.8.4.3 Segmentation By Application
      • 12.8.4.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 12.8.4.3.2 Asthma
      • 12.8.4.3.3 Other Applications
    • 12.8.4.4 Segmentation By End User
      • 12.8.4.4.1 Hospitals
      • 12.8.4.4.2 Physician & Clinics
      • 12.8.4.4.3 Diagnostic Centers
      • 12.8.4.4.4 Homecare Settings
      • 12.8.4.4.5 Other Facilities
  • 12.8.5 Spain
    • 12.8.5.1 Segmentation By Type
      • 12.8.5.1.1 Volume Measurement
      • 12.8.5.1.2 Peak Flow
    • 12.8.5.2 Segmentation By Product Type
      • 12.8.5.2.1 Devices
      • 12.8.5.2.2 Accessories & Consumables
      • 12.8.5.2.3 Software
    • 12.8.5.3 Segmentation By Application
      • 12.8.5.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 12.8.5.3.2 Asthma
      • 12.8.5.3.3 Other Applications
    • 12.8.5.4 Segmentation By End User
      • 12.8.5.4.1 Hospitals
      • 12.8.5.4.2 Physician & Clinics
      • 12.8.5.4.3 Diagnostic Centers
      • 12.8.5.4.4 Homecare Settings
      • 12.8.5.4.5 Other Facilities
  • 12.8.6 Italy
    • 12.8.6.1 Segmentation By Type
      • 12.8.6.1.1 Volume Measurement
      • 12.8.6.1.2 Peak Flow
    • 12.8.6.2 Segmentation By Product Type
      • 12.8.6.2.1 Devices
      • 12.8.6.2.2 Accessories & Consumables
      • 12.8.6.2.3 Software
    • 12.8.6.3 Segmentation By Application
      • 12.8.6.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 12.8.6.3.2 Asthma
      • 12.8.6.3.3 Other Applications
    • 12.8.6.4 Segmentation By End User
      • 12.8.6.4.1 Hospitals
      • 12.8.6.4.2 Physician & Clinics
      • 12.8.6.4.3 Diagnostic Centers
      • 12.8.6.4.4 Homecare Settings
      • 12.8.6.4.5 Other Facilities
  • 12.8.7 Rest of Europe
    • 12.8.7.1 Segmentation By Type
      • 12.8.7.1.1 Volume Measurement
      • 12.8.7.1.2 Peak Flow
    • 12.8.7.2 Segmentation By Product Type
      • 12.8.7.2.1 Devices
      • 12.8.7.2.2 Accessories & Consumables
      • 12.8.7.2.3 Software
    • 12.8.7.3 Segmentation By Application
      • 12.8.7.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 12.8.7.3.2 Asthma
      • 12.8.7.3.3 Other Applications
    • 12.8.7.4 Segmentation By End User
      • 12.8.7.4.1 Hospitals
      • 12.8.7.4.2 Physician & Clinics
      • 12.8.7.4.3 Diagnostic Centers
      • 12.8.7.4.4 Homecare Settings
      • 12.8.7.4.5 Other Facilities

Chapter 13. Asia Pacific Market

• 13.1 Market Overview
• 13.2 Key Factors Impacting Market
  • 13.2.1 Market Drivers
  • 13.2.2 Market Restraints
  • 13.2.3 Market Opportunities
  • 13.2.4 Market Challenges
  • 13.2.5 Market Trends
  • 13.2.6 State of Competition
  • 13.2.7 Market Consolidation
  • 13.2.8 Key Customer Criteria
  • 13.2.9 Product Life Cycle
• 13.3 Segmentation By Type
  • 13.3.1 Volume Measurement
  • 13.3.2 Peak Flow Meters
• 13.4 Segmentation By Product Type
  • 13.4.1 Devices
  • 13.4.2 Accessories & Consumables
  • 13.4.3 Software
• 13.5 Segmentation By Application
  • 13.5.1 Chronic Obstructive Pulmonary Disorder (COPD)
  • 13.5.2 Asthma
  • 13.5.3 Other Application
• 13.6 Segmentation By End User
  • 13.6.1 Hospitals
  • 13.6.2 Physician & Clinics
  • 13.6.3 Diagnostic Centers
  • 13.6.4 Homecare Settings
  • 13.6.5 Other Facilities
• 13.7 Segmentation By Country
  • 13.7.1 China
    • 13.7.1.1 Segmentation By Type
      • 13.7.1.1.1 Volume Measurement
      • 13.7.1.1.2 Peak Flow
    • 13.7.1.2 Segmentation By Product Type
      • 13.7.1.2.1 Devices
      • 13.7.1.2.2 Accessories & Consumables
      • 13.7.1.2.3 Software
    • 13.7.1.3 Segmentation By Application
      • 13.7.1.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 13.7.1.3.2 Asthma
      • 13.7.1.3.3 Other Applications
    • 13.7.1.4 Segmentation By End User
      • 13.7.1.4.1 Hospitals
      • 13.7.1.4.2 Physician & Clinics
      • 13.7.1.4.3 Diagnostic Centers
      • 13.7.1.4.4 Homecare Settings
      • 13.7.1.4.5 Other Facilities
  • 13.7.2 Japan
    • 13.7.2.1 Segmentation By Type
      • 13.7.2.1.1 Volume Measurement
      • 13.7.2.1.2 Peak Flow
    • 13.7.2.2 Segmentation By Product Type
      • 13.7.2.2.1 Devices
      • 13.7.2.2.2 Accessories & Consumables
      • 13.7.2.2.3 Software
    • 13.7.2.3 Segmentation By Application
      • 13.7.2.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 13.7.2.3.2 Asthma
      • 13.7.2.3.3 Other Applications
    • 13.7.2.4 Segmentation By End User
      • 13.7.2.4.1 Hospitals
      • 13.7.2.4.2 Physician & Clinics
      • 13.7.2.4.3 Diagnostic Centers
      • 13.7.2.4.4 Homecare Settings
      • 13.7.2.4.5 Other Facilities
  • 13.7.3 India
    • 13.7.3.1 Segmentation By Type
      • 13.7.3.1.1 Volume Measurement
      • 13.7.3.1.2 Peak Flow
    • 13.7.3.2 Segmentation By Product Type
      • 13.7.3.2.1 Devices
      • 13.7.3.2.2 Accessories & Consumables
      • 13.7.3.2.3 Software
    • 13.7.3.3 Segmentation By Application
      • 13.7.3.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 13.7.3.3.2 Asthma
      • 13.7.3.3.3 Other Applications
    • 13.7.3.4 Segmentation By End User
      • 13.7.3.4.1 Hospitals
      • 13.7.3.4.2 Physician & Clinics
      • 13.7.3.4.3 Diagnostic Centers
      • 13.7.3.4.4 Homecare Settings
      • 13.7.3.4.5 Other Facilities
  • 13.7.4 South Korea
    • 13.7.4.1 Segmentation By Type
      • 13.7.4.1.1 Volume Measurement
      • 13.7.4.1.2 Peak Flow
    • 13.7.4.2 Segmentation By Product Type
      • 13.7.4.2.1 Devices
      • 13.7.4.2.2 Accessories & Consumables
      • 13.7.4.2.3 Software
    • 13.7.4.3 Segmentation By Application
      • 13.7.4.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 13.7.4.3.2 Asthma
      • 13.7.4.3.3 Other Applications
    • 13.7.4.4 Segmentation By End User
      • 13.7.4.4.1 Hospitals
      • 13.7.4.4.2 Physician & Clinics
      • 13.7.4.4.3 Diagnostic Centers
      • 13.7.4.4.4 Homecare Settings
      • 13.7.4.4.5 Other Facilities
  • 13.7.5 Singapore
    • 13.7.5.1 Segmentation By Type
      • 13.7.5.1.1 Volume Measurement
      • 13.7.5.1.2 Peak Flow
    • 13.7.5.2 Segmentation By Product Type
      • 13.7.5.2.1 Devices
      • 13.7.5.2.2 Accessories & Consumables
      • 13.7.5.2.3 Software
    • 13.7.5.3 Segmentation By Application
      • 13.7.5.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 13.7.5.3.2 Asthma
      • 13.7.5.3.3 Other Applications
    • 13.7.5.4 Segmentation By End User
      • 13.7.5.4.1 Hospitals
      • 13.7.5.4.2 Physician & Clinics
      • 13.7.5.4.3 Diagnostic Centers
      • 13.7.5.4.4 Homecare Settings
      • 13.7.5.4.5 Other Facilities
  • 13.7.6 Malaysia
    • 13.7.6.1 Segmentation By Type
      • 13.7.6.1.1 Volume Measurement
      • 13.7.6.1.2 Peak Flow
    • 13.7.6.2 Segmentation By Product Type
      • 13.7.6.2.1 Devices
      • 13.7.6.2.2 Accessories & Consumables
      • 13.7.6.2.3 Software
    • 13.7.6.3 Segmentation By Application
      • 13.7.6.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 13.7.6.3.2 Asthma
      • 13.7.6.3.3 Other Applications
    • 13.7.6.4 Segmentation By End User
      • 13.7.6.4.1 Hospitals
      • 13.7.6.4.2 Physician & Clinics
      • 13.7.6.4.3 Diagnostic Centers
      • 13.7.6.4.4 Homecare Settings
      • 13.7.6.4.5 Other Facilities
  • 13.7.7 Rest of Asia Pacific
    • 13.7.7.1 Segmentation By Type
      • 13.7.7.1.1 Volume Measurement
      • 13.7.7.1.2 Peak Flow
    • 13.7.7.2 Segmentation By Product Type
      • 13.7.7.2.1 Devices
      • 13.7.7.2.2 Accessories & Consumables
      • 13.7.7.2.3 Software
    • 13.7.7.3 Segmentation By Application
      • 13.7.7.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 13.7.7.3.2 Asthma
      • 13.7.7.3.3 Other Applications
    • 13.7.7.4 Segmentation By End User
      • 13.7.7.4.1 Hospitals
      • 13.7.7.4.2 Physician & Clinics
      • 13.7.7.4.3 Diagnostic Centers
      • 13.7.7.4.4 Homecare Settings
      • 13.7.7.4.5 Other Facilities

Chapter 14. LAMEA Market

• 14.1 Market Overview
• 14.2 Key Factors Impacting Market
  • 14.2.1 Market Drivers
  • 14.2.2 Market Restraints
  • 14.2.3 Market Opportunities
  • 14.2.4 Market Challenges
  • 14.2.5 Market Trends
  • 14.2.6 State of Competition
  • 14.2.7 Market Consolidation
  • 14.2.8 Key Customer Criteria
• 14.3 Product Life Cycle
• 14.4 Segmentation By Type
  • 14.4.1 Volume Measurement
  • 14.4.2 Peak Flow Meters
• 14.5 Segmentation By Product Type
  • 14.5.1 Devices
  • 14.5.2 Accessories & Consumables
  • 14.5.3 Software
• 14.6 Segmentation By Application
  • 14.6.1 Chronic Obstructive Pulmonary Disorder (COPD)
  • 14.6.2 Asthma
  • 14.6.3 Other Application
• 14.7 Segmentation By End User
  • 14.7.1 Hospitals
  • 14.7.2 Physician & Clinics
  • 14.7.3 Diagnostic Centers
  • 14.7.4 Homecare Settings
  • 14.7.5 Other Facilities
• 14.8 Segmentation By Country
  • 14.8.1 Brazil
    • 14.8.1.1 Segmentation By Type
      • 14.8.1.1.1 Volume Measurement
      • 14.8.1.1.2 Peak Flow
    • 14.8.1.2 Segmentation By Product Type
      • 14.8.1.2.1 Devices
      • 14.8.1.2.2 Accessories & Consumables
      • 14.8.1.2.3 Software
    • 14.8.1.3 Segmentation By Application
      • 14.8.1.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 14.8.1.3.2 Asthma
      • 14.8.1.3.3 Other Applications
    • 14.8.1.4 Segmentation By End User
      • 14.8.1.4.1 Hospitals
      • 14.8.1.4.2 Physician & Clinics
      • 14.8.1.4.3 Diagnostic Centers
      • 14.8.1.4.4 Homecare Settings
      • 14.8.1.4.5 Other Facilities
  • 14.8.2 Argentina
    • 14.8.2.1 Segmentation By Type
      • 14.8.2.1.1 Volume Measurement
      • 14.8.2.1.2 Peak Flow
    • 14.8.2.2 Segmentation By Product Type
      • 14.8.2.2.1 Devices
      • 14.8.2.2.2 Accessories & Consumables
      • 14.8.2.2.3 Software
    • 14.8.2.3 Segmentation By Application
      • 14.8.2.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 14.8.2.3.2 Asthma
      • 14.8.2.3.3 Other Applications
    • 14.8.2.4 Segmentation By End User
      • 14.8.2.4.1 Hospitals
      • 14.8.2.4.2 Physician & Clinics
      • 14.8.2.4.3 Diagnostic Centers
      • 14.8.2.4.4 Homecare Settings
      • 14.8.2.4.5 Other Facilities
  • 14.8.3 UAE
    • 14.8.3.1 Segmentation By Type
      • 14.8.3.1.1 Volume Measurement
      • 14.8.3.1.2 Peak Flow
    • 14.8.3.2 Segmentation By Product Type
      • 14.8.3.2.1 Devices
      • 14.8.3.2.2 Accessories & Consumables
      • 14.8.3.2.3 Software
    • 14.8.3.3 Segmentation By Application
      • 14.8.3.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 14.8.3.3.2 Asthma
      • 14.8.3.3.3 Other Applications
    • 14.8.3.4 Segmentation By End User
      • 14.8.3.4.1 Hospitals
      • 14.8.3.4.2 Physician & Clinics
      • 14.8.3.4.3 Diagnostic Centers
      • 14.8.3.4.4 Homecare Settings
      • 14.8.3.4.5 Other Facilities
  • 14.8.4 Saudi Arabia
    • 14.8.4.1 Segmentation By Type
      • 14.8.4.1.1 Volume Measurement
      • 14.8.4.1.2 Peak Flow
    • 14.8.4.2 Segmentation By Product Type
      • 14.8.4.2.1 Devices
      • 14.8.4.2.2 Accessories & Consumables
      • 14.8.4.2.3 Software
    • 14.8.4.3 Segmentation By Application
      • 14.8.4.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 14.8.4.3.2 Asthma
      • 14.8.4.3.3 Other Applications
    • 14.8.4.4 Segmentation By End User
      • 14.8.4.4.1 Hospitals
      • 14.8.4.4.2 Physician & Clinics
      • 14.8.4.4.3 Diagnostic Centers
      • 14.8.4.4.4 Homecare Settings
      • 14.8.4.4.5 Other Facilities
  • 14.8.5 South Africa
    • 14.8.5.1 Segmentation By Type
      • 14.8.5.1.1 Volume Measurement
      • 14.8.5.1.2 Peak Flow
    • 14.8.5.2 Segmentation By Product Type
      • 14.8.5.2.1 Devices
      • 14.8.5.2.2 Accessories & Consumables
      • 14.8.5.2.3 Software
    • 14.8.5.3 Segmentation By Application
      • 14.8.5.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 14.8.5.3.2 Asthma
      • 14.8.5.3.3 Other Applications
    • 14.8.5.4 Segmentation By End User
      • 14.8.5.4.1 Hospitals
      • 14.8.5.4.2 Physician & Clinics
      • 14.8.5.4.3 Diagnostic Centers
      • 14.8.5.4.4 Homecare Settings
      • 14.8.5.4.5 Other Facilities
  • 14.8.6 Nigeria
    • 14.8.6.1 Segmentation By Type
      • 14.8.6.1.1 Volume Measurement
      • 14.8.6.1.2 Peak Flow
    • 14.8.6.2 Segmentation By Product Type
      • 14.8.6.2.1 Devices
      • 14.8.6.2.2 Accessories & Consumables
      • 14.8.6.2.3 Software
    • 14.8.6.3 Segmentation By Application
      • 14.8.6.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 14.8.6.3.2 Asthma
      • 14.8.6.3.3 Other Applications
    • 14.8.6.4 Segmentation By End User
      • 14.8.6.4.1 Hospitals
      • 14.8.6.4.2 Physician & Clinics
      • 14.8.6.4.3 Diagnostic Centers
      • 14.8.6.4.4 Homecare Settings
      • 14.8.6.4.5 Other Facilities
  • 14.8.7 Rest of LAMEA
    • 14.8.7.1 Segmentation By Type
      • 14.8.7.1.1 Volume Measurement
      • 14.8.7.1.2 Peak Flow
    • 14.8.7.2 Segmentation By Product Type
      • 14.8.7.2.1 Devices
      • 14.8.7.2.2 Accessories & Consumables
      • 14.8.7.2.3 Software
    • 14.8.7.3 Segmentation By Application
      • 14.8.7.3.1 Chronic Obstructive Pulmonary Disorder (COPD)
      • 14.8.7.3.2 Asthma
      • 14.8.7.3.3 Other Applications
    • 14.8.7.4 Segmentation By End User
      • 14.8.7.4.1 Hospitals
      • 14.8.7.4.2 Physician & Clinics
      • 14.8.7.4.3 Diagnostic Centers
      • 14.8.7.4.4 Homecare Settings
      • 14.8.7.4.5 Other Facilities

Chapter 15. Company Snapshots

• 15.1 Vyaire Medical, Inc.
  • 15.1.1 Business Overview
  • 15.1.2 Key Information
  • 15.1.3 Company Focus on Spirometer Market
  • 15.1.4 Strategic Insights
  • 15.1.5 Strategy Deployed
  • 15.1.6 Product & Service Portfolio
  • 15.1.7 Capability Overview
  • 15.1.8 Technology & Innovation Focus
  • 15.1.9 SWOT Analysis
  • 15.1.10 Weaknesses
  • 15.1.11 Opportunities
  • 15.1.12 Threats / External Constraints
  • 15.1.13 Customers / End Users
  • 15.1.14 Competitive Positioning
  • 15.1.15 Key Differentiators
  • 15.1.16 Portfolio Matrix
  • 15.1.17 Future Outlook
• 15.2 ndd Medical Technologies
  • 15.2.1 Business Overview
  • 15.2.2 Key Information
  • 15.2.3 Company Focus on Spirometer Market
  • 15.2.4 Strategic Insights
  • 15.2.5 Strategy Deployed
  • 15.2.6 Product & Service Portfolio
  • 15.2.7 Capability Overview
  • 15.2.8 Technology & Innovation Focus
  • 15.2.9 SWOT Analysis
  • 15.2.10 Weaknesses
  • 15.2.11 Opportunities
  • 15.2.12 Threats / External Constraints
  • 15.2.13 Customers / End Users
  • 15.2.14 Competitive Positioning
  • 15.2.15 Key Differentiators
  • 15.2.16 Portfolio Matrix
  • 15.2.17 Future Outlook
• 15.3 Medical International Research S.p.A. (MIR)
  • 15.3.1 Business Overview
  • 15.3.2 Key Information
  • 15.3.3 Company Focus on Spirometer Market
  • 15.3.4 Strategic Insights
  • 15.3.5 Strategy Deployed
  • 15.3.6 Product & Service Portfolio
  • 15.3.7 Capability Overview
  • 15.3.8 Technology & Innovation Focus
  • 15.3.9 SWOT Analysis
  • 15.3.10 Weaknesses
  • 15.3.11 Opportunities
  • 15.3.12 Threats / External Constraints
  • 15.3.13 Customers / End Users
  • 15.3.14 Competitive Positioning
  • 15.3.15 Key Differentiators
  • 15.3.16 Portfolio Matrix
  • 15.3.17 Future Outlook
• 15.4 Vitalograph Ltd.
  • 15.4.1 Business Overview
  • 15.4.2 Key Information
  • 15.4.3 Company Focus on Spirometer Market
  • 15.4.4 Strategic Insights
  • 15.4.5 Strategy Deployed
  • 15.4.6 Product & Service Portfolio
  • 15.4.7 Capability Overview
  • 15.4.8 Technology & Innovation Focus
  • 15.4.9 SWOT Analysis
  • 15.4.10 Weaknesses
  • 15.4.11 Opportunities
  • 15.4.12 Threats / External Constraints
  • 15.4.13 Customers / End Users
  • 15.4.14 Competitive Positioning
  • 15.4.15 Key Differentiators
  • 15.4.16 Portfolio Matrix
  • 15.4.17 Future Outlook
• 15.5 SCHILLER AG
  • 15.5.1 Business Overview
  • 15.5.2 Key Information
  • 15.5.3 Company Focus on Spirometer Market
  • 15.5.4 Strategic Insights
  • 15.5.5 Strategy Deployed
  • 15.5.6 Product & Service Portfolio
  • 15.5.7 Capability Overview
  • 15.5.8 Technology & Innovation Focus
  • 15.5.9 SWOT Analysis
  • 15.5.10 Weaknesses
  • 15.5.11 Opportunities
  • 15.5.12 Threats / External Constraints
  • 15.5.13 Customers / End Users
  • 15.5.14 Competitive Positioning
  • 15.5.15 Key Differentiators
  • 15.5.16 Portfolio Matrix
  • 15.5.17 Future Outlook
• 15.6 MGC Diagnostics Corporation
  • 15.6.1 Business Overview
  • 15.6.2 Key Information
  • 15.6.3 Company Focus on Spirometer Market
  • 15.6.4 Strategic Insights
  • 15.6.5 Strategy Deployed
  • 15.6.6 Product & Service Portfolio
  • 15.6.7 Capability Overview
  • 15.6.8 Technology & Innovation Focus
  • 15.6.9 SWOT Analysis
  • 15.6.10 Weaknesses
  • 15.6.11 Opportunities
  • 15.6.12 Threats / External Constraints
  • 15.6.13 Customers / End Users
  • 15.6.14 Competitive Positioning
  • 15.6.15 Key Differentiators
  • 15.6.16 Portfolio Matrix
  • 15.6.17 Future Outlook
• 15.7 COSMED S.r.l.
  • 15.7.1 Business Overview
  • 15.7.2 Key Information
  • 15.7.3 Company Focus on Spirometer Market
  • 15.7.4 Strategic Insights
  • 15.7.5 Strategy Deployed
  • 15.7.6 Product & Service Portfolio
  • 15.7.7 C